News | Radiation Therapy | September 14, 2017

Clinical Trials and Cutting-Edge Radiation Oncology Research to Be Featured at ASTRO 2017

Studies presented will explore innovative treatment approaches, and ways to enhance patient quality-of-life and well-being

Clinical Trials and Cutting-Edge Radiation Oncology Research to Be Featured at ASTRO 2017

September 14, 2017 – The program for the 2017 Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 24-27 in San Diego, will feature advances in cancer research, including reports from phase II and III clinical trials. Studies that examine innovative treatments, such as immunotherapy, mental health influences on cancer outcomes, and optimal radiation dosing and sequencing, will also be presented at the largest meeting for the field of radiation oncology.

The meeting is expected to attract more than 11,000 attendees to the San Diego Convention Center. Researchers selected for the press program will share their findings in a series of news briefings and webcast live to registered press. The schedule is as follows:

The Science of Radiation Oncology: Innovative Approaches
Sunday, Sept. 24, 1:00 p.m. – 2:00 p.m. Pacific time; moderator Brian Czito, M.D., FASTRO, Duke University

Quality Care in Radiation Oncology: Refining Treatments
Monday, September 25, 11:00 a.m. – 12:00 p.m. Pacific time; moderator, Paul Harari, M.D., FASTRO, ASTRO President-elect, University of Wisconsin

The Healing Art of Radiation Oncology: Patient Well-being
Tuesday, September 26, 1:00 p.m. – 2:00 p.m. Pacific time; moderator, Brian Kavanagh, M.D., MPH, FASTRO, ASTRO President, University of Colorado

In addition, the meeting will feature keynote addresses from Richard D. Zane, M.D., FAAEM, chief innovation officer for the University of Colorado Health System; Lucy Kalanithi, M.D., FACP, widow of Paul Kalanithi, M.D., the best-selling author of “When Breath Becomes Air,” with Heather Wakelee, M.D., Paul’s oncologist; and Vinay K. Prasad, M.D., MPH, an assistant professor of medicine at the Oregon Health and Science University.

During the four-day meeting, more than 200 exhibitors will demonstrate cutting-edge technology and medical device innovations for radiation oncology.

For more information: www.astro.org

Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
The patient’s wife changes the Optune array. Clinical trials indicate that the electrical fields emitted by Optune have the potential to lengthen the lives of patients with glioblastoma.

The patient’s wife changes the Optune array. Clinical trials indicate that the electrical fields emitted by Optune have the potential to lengthen the lives of patients with glioblastoma.

Feature | Radiation Oncology | November 06, 2018 | By Greg Freiherr
Approximately 11,000 professionals attended the four-day meeting of the...